OTC · Financial Statements
Evelo Biosciences, Inc. (EVLO) Financial Statements
$0.00
OTC: EVLO
Market Cap $1898
Overview Financials Dividend Evelo Biosciences, Inc. most recently reported annual revenue of $0, net profit of $-115.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $0 $0 $0 $0 $0 Operating Profit $-58.0M $-86.0M $-92.0M $-115.0M $-108.0M Net Profit $-54.0M $-86.0M $-94.0M $-122.0M $-115.0M EPS $-49.25 $-53.49 $-47.45 $-46.18 $-26.28 Op Margin — — — — —
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $160.0M $91.0M $91.0M $88.0M $64.0M Total Liabilities $23.0M $31.0M $60.0M $79.0M $69.0M Cash $148.0M $78.0M $69.0M $68.0M $48.0M Borrowings $12.0M $20.0M $40.0M $56.0M $51.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-47.0M $-72.0M $-73.0M $-97.0M $-101.0M Investing Cash Flow $-66.0M $49.0M $-3.0M $-3.0M $-1.0M Financing Cash Flow $0 $1.0M $0 $1.0M $0 Net Cash Flow $55.0M $-15.0M $-9.0M $-1.0M $-21.0M Free Cash Flow $-53.0M $-75.0M $-74.0M $-98.0M $-102.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.03 FCF Yield -5366543.73% Quick Ratio 4.16 Interest Coverage -23.22 Return 1Y -80.00% Return 3Y -100.00% Return 5Y —
Screens featuring this stock